4.4 Review

Doxorubicin-induced cardiotoxicity: causative factors and possible interventions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway

Dalia A. Shabaan et al.

Summary: This study evaluated the cardioprotective effects of CoQ10 against Dox-induced cardiotoxicity and found that CoQ10 can protect cardiomyocytes by regulating the expression of apoptotic genes.

TISSUE BARRIERS (2023)

Article Chemistry, Multidisciplinary

Comprehending Cardiac Dysfunction by Oxidative Stress: Untargeted Metabolomics of In Vitro Samples

Alan Goncalves Amaral et al.

Summary: Cardiovascular diseases (CVDs) are complex noncommunicable diseases with a high mortality rate. Oxidative stress (OS) plays a pivotal role in CVC, and studying cellular metabolomics can help evaluate cardiac dysfunction. The results of this study suggest that LC-MS method is effective for studying cardiomyocyte metabolism and has good fitness and predictability.

FRONTIERS IN CHEMISTRY (2022)

Article Materials Science, Biomaterials

Novel multi-responsive and sugarcane bagasse cellulose-based nanogels for controllable release of doxorubicin hydrochloride

Yuanfeng Pan et al.

Summary: This study successfully developed multi-responsive nanogels based on modified sugarcane bagasse cellulose, which exhibited good stability, ideal particle size, and effective loading of doxorubicin hydrochloride. The drug release efficiency of nanogels was also influenced by reducing agent, pH, and temperature.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Article Pharmacology & Pharmacy

Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics

Apiwan Arinno et al.

Summary: Studies have shown that melatonin and metformin can reduce oxidative stress, inflammation, autophagy, apoptosis, and improve mitochondrial function to protect against Doxorubicin-induced cardiotoxicity.

BIOCHEMICAL PHARMACOLOGY (2021)

Review Oncology

Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy

Muhammad Sohail et al.

Summary: DOX exhibits strong anticancer activity but can cause irreversible cardiotoxicity with cumulative doses above 550mg/m2. Recent patents and research articles have focused on various aspects of DOX, including registered patent analysis, pharmacological action, toxicity minimization, and formulation development.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

Review Oncology

Metabolic Aspects of Anthracycline Cardiotoxicity

Michele Russo et al.

Summary: Heart failure is increasingly being recognized as a major complication of chemotherapy regimens, with doxorubicin (DOXO) remaining a commonly used but cardiotoxic anticancer agent. The molecular level effects of DOXO on the heart include mitochondrial dysfunction, DNA damage, and apoptosis. Dexrazoxane is currently the only FDA-approved cardioprotectant for patients treated with DOXO. However, research on the impact of DOXO on cardiac metabolism and potential pharmacological targets for prevention or treatment of DOXO cardiomyopathy is still ongoing.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Oncology

Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?

Mojtaba Mollaei et al.

Summary: Chemotherapeutic drugs, radiation, and surgery have different mechanisms in cancer treatment. Chemoresistance and tumor relapse remain major complications. Research focuses on intracellular signaling pathways in different drug families, as well as the use of combination therapies and emerging treatments.

TRANSLATIONAL ONCOLOGY (2021)

Review Cell Biology

Regulated cell death pathways in doxorubicin-induced cardiotoxicity

Effimia Christidi et al.

Summary: This review summarizes recent advances in understanding the mechanisms by which Doxorubicin induces cardiomyocyte death, including pathways such as autophagy, ferroptosis, necroptosis, pyroptosis, and apoptosis. Understanding these mechanisms may help identify novel therapeutic agents and lead to more targeted approaches to cardiotoxicity testing.

CELL DEATH & DISEASE (2021)

Article Cardiac & Cardiovascular Systems

The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study

Maryam Rahmanifard et al.

Summary: The study aimed to evaluate the cardioprotective effects of coenzyme Q10 and lisinopril against doxorubicin-induced cardiac toxicity in rats. Results showed that Q10 and LIS were able to prevent some stereological parameters and ECG changes, improve catalase activity, and reduce MDA concentration in the doxorubicin-treated group, indicating their significant cardioprotective effects.

CARDIOVASCULAR TOXICOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Eduard Jirkovsky et al.

Summary: This study reveals that the cardioprotective effects of DEX against anthracycline-induced heart failure are attributed to interactions with TOP2B rather than metal chelation or protection against direct oxidative damage. ADR-925 did not show significant protective effects on the heart in the experiments.

CIRCULATION-HEART FAILURE (2021)

Article Biochemistry & Molecular Biology

Integration of fluxome and transcriptome data in Saccharomyces cerevisiae offers unique features of doxorubicin and imatinib

Hilal Taymaz-Nikerel

Summary: Analysis of the cellular response of the eukaryotic model microorganism Saccharomyces cerevisiae to the chemotherapy drugs doxorubicin and imatinib revealed differences in their mechanisms of action and regulatory pathways, providing insights for developing new drug targets.

MOLECULAR OMICS (2021)

Article Biochemistry & Molecular Biology

Time-dependent re-organization of biological processes by the analysis of the dynamic transcriptional response of yeast cells to doxorubicin

Muhammed Erkan Karabekmez et al.

Summary: Doxorubicin is an effective chemotherapeutic reagent with unclear molecular mechanisms and severe side effects. Yeast cells show time-dependent responses to doxorubicin, including short-term, mid-term, and long-term reactions, with significant effects on DNA replication and repair processes observed after 60 minutes. Regulatory factors such as Fhl1p, Mbp1p, and Mcm1p play key roles in tuning gene expression in response to the drug.

MOLECULAR OMICS (2021)

Article Cardiac & Cardiovascular Systems

Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat

Ana Flavia M. Botelho et al.

CARDIOVASCULAR TOXICOLOGY (2020)

Article Biochemistry & Molecular Biology

Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation

Carmine Rocca et al.

ANTIOXIDANTS & REDOX SIGNALING (2020)

Article Nanoscience & Nanotechnology

Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor

Jian Zhang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Review Chemistry, Multidisciplinary

A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market

Mara Goncalves et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Cardiac & Cardiovascular Systems

Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis

Xuexian Fang et al.

CIRCULATION RESEARCH (2020)

Review Biochemistry & Molecular Biology

Iron Metabolism in Cancer Progression

Stefania Forciniti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity

Tomonori Tadokoro et al.

JCI INSIGHT (2020)

Article Biochemical Research Methods

Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy in Vivo

Yilun Wu et al.

BIOCONJUGATE CHEMISTRY (2020)

Article Multidisciplinary Sciences

Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts

T. R. Mancilla et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency

Christina Schindler et al.

PLOS ONE (2019)

Article Cell Biology

Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells

James H. Doroshow

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Pharmacology & Pharmacy

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Xu Wang et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Cell Biology

Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity

K. Melodi McSweeney et al.

CELL DEATH DISCOVERY (2019)

Review Cardiac & Cardiovascular Systems

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Steven J. Forrester et al.

CIRCULATION RESEARCH (2018)

Article Multidisciplinary Sciences

Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells

Hilal Taymaz-Nikerel et al.

SCIENTIFIC REPORTS (2018)

Article Pharmacology & Pharmacy

Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles

Marziyeh Zare et al.

ADVANCED PHARMACEUTICAL BULLETIN (2018)

Article Pharmacology & Pharmacy

Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations

Ruijuan Luo et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Article Mathematical & Computational Biology

A systematic analysis of FDA-approved anticancer drugs

Jingchun Sun et al.

BMC SYSTEMS BIOLOGY (2017)

Review Oncology

One-carbon metabolism in cancer

Alice C. Newman et al.

BRITISH JOURNAL OF CANCER (2017)

Article Biochemical Research Methods

A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity

Bernardo L. de Oliveira et al.

PLOS COMPUTATIONAL BIOLOGY (2016)

Article Medicine, Research & Experimental

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Yoshihiko Ichikawa et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Biochemistry & Molecular Biology

Transcription-generated torsional stress destabilizes nucleosomes

Sheila S. Teves et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity

Marzia Lotrionte et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Oncology

Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues

Krupa J. Patel et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

Doxorubicin Enhances Nucleosome Turnover around Promoters

Fan Yang et al.

CURRENT BIOLOGY (2013)

Article Pharmacology & Pharmacy

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Oktay Tacar et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

Article Oncology

Lack of Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures

Heather Greenlee et al.

INTEGRATIVE CANCER THERAPIES (2012)

Article Biochemistry & Molecular Biology

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Sui Zhang et al.

NATURE MEDICINE (2012)

Article Biochemistry & Molecular Biology

Oxidative stress modulates PPARγ in vascular endothelial cells

Carmelo Blanquicett et al.

FREE RADICAL BIOLOGY AND MEDICINE (2010)

Article Biotechnology & Applied Microbiology

Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity

Lu Fan et al.

Pharmacogenetics and Genomics (2010)

Article Pharmacology & Pharmacy

Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver

Nina Kassner et al.

DRUG METABOLISM AND DISPOSITION (2008)

Article Biochemistry & Molecular Biology

Interaction of anthracyclines with iron responsive element mRNAs

Joshua C. Canzoneri et al.

NUCLEIC ACIDS RESEARCH (2008)

Review Pharmacology & Pharmacy

Anthracycline cardiotoxicity

Robin L. Jones et al.

EXPERT OPINION ON DRUG SAFETY (2006)

Article Medicine, Research & Experimental

Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide

H Mizutani et al.

LIFE SCIENCES (2005)

Article Multidisciplinary Sciences

Genomic instability in mice lacking histone H2AX

A Celeste et al.

SCIENCE (2002)

Article Multidisciplinary Sciences

Exosome-mediated recognition and degradation of mRNAs lacking a termination codon

A van Hoof et al.

SCIENCE (2002)

Article Multidisciplinary Sciences

An mRNA surveillance mechanism that eliminates transcripts lacking termination codons

PA Frischmeyer et al.

SCIENCE (2002)